Sivitz. Impaired utilization of membrane potential by complex II-energized mitochondria of obese, diabetic mice assessed using ADP recycling methodology. Am J Physiol Regul Integr Comp Physiol 311: R756 -R763, 2016. First published August 22, 2016 doi:10.1152/ajpregu.00232.2016.-Recently, we used an ADP recycling approach to examine mouse skeletal muscle (SkM) mitochondrial function over respiratory states intermittent between state 3 and 4. We showed that respiration energized at complex II by succinate, in the presence of rotenone to block complex I, progressively increased with incremental additions of ADP. However, in the absence of rotenone, respiration peaked at low [ADP] but then dropped markedly as [ADP] was further increased. Here, we tested the hypothesis that these respiratory dynamics would differ between mitochondria of mice fed high fat (HF) and treated with a low dose of streptozotocin to mimic Type 2 diabetes and mitochondria from controls. We found that respiration and ATP production on succinate alone for both control and diabetic mice increased to a maximum at low [ADP] but dropped markedly as [ADP] was incrementally increased. However, peak respiration by the diabetic mitochondria required a higher [ADP] (right shift in the curve of O 2 flux vs.
mitochondria; diabetes; obesity; succinate; bioenergetics ALMOST ALL FUNCTIONAL STUDIES of isolated mitochondria as affected by physiological or pathophysiological conditions (including diabetes and obesity) have been carried out under conditions of state 4 respiration (absence of ADP) or state 3 (ADP added to induce transient maximal ATP production) conditions (5) . However, a problem with such studies is that mitochondria in vivo do not function at either state 3 or 4, but rather in between. Moreover, when ADP is added to measure state 3 respiration, the nucleotide is usually added in amounts that induce near-maximal O 2 flux until nearly all is consumed. Thereafter, respiration quickly returns to state 4, leaving no indication of mitochondrial function under actual intermediate respiratory conditions. Mitochondrial function over intermediate respiratory states has been assessed in the past by different methods designed to regenerate ADP for phosphorylation. These include the use of creatine plus creatine kinase (6, 29, 30) , ATPase with excess ATP (6, 9 -11) , or glucose plus hexokinase (HK) (22, 30) . Most of these studies were directed at liver mitochondria and used for kinetic analysis to determine flux control parameters and not applied to physiological conditions.
In recent work (1), we used a 2-deoxyglucose/HK energy clamp (an ADP recycling approach) to examine mouse skeletal muscle mitochondrial function over respiratory states intermittent between states 3 and 4. Under these conditions, ADP concentrations external to mitochondria are clamped at levels determined by the amount of ADP added. Using this technique, we showed that mitochondrial respiration by isolated skeletal muscle (SkM) mitochondria energized at complex II by succinate, in the presence of rotenone to block complex I, progressively increased with increasing [ADP] . However, in the absence of rotenone, respiration peaked at low [ADP] but then dropped markedly as [ADP] was further increased. This biphasic pattern was most pronounced in skeletal muscle, but also clearly evident in mitochondria from the heart and brain while barely evident for the liver (1) .
Given our observation that the complex I inhibitor altered the dynamic relationship between succinate-supported respiration and [ADP] (1) and evidence that complex I activity is impaired in Type 2 diabetes (20) , we tested the hypothesis that the dynamics of O 2 flux versus [ADP] in mitochondria energized by succinate would differ between mitochondria from SkM of diabetic compared with control mice. In fact, we did observe dynamic diabetes-induced changes in O 2 flux versus [ADP] .
However, these changes were accompanied by perturbations in ATP production and membrane potential (⌬⌿) which, taken together, offer a mechanistic explanation apart from alterations in complex I.
MATERIALS AND METHODS
Reagents and supplies. Reagents, kits, and supplies were as specified or purchased from standard sources.
Animal procedures. Mice were maintained according to National Institutes of Health guidelines and the protocol was approved by our Iowa City Veterans Affairs Medical Center Institutional Animal Care and Use Committee. Mice were monitored daily for any abnormality in movement, feeding, or distressed appearance. No animal became sick or died before the experimental end point. Mice were euthanized by isoflurane inhalation followed by thoracotomy and cardiac puncture.
To model Type 2 diabetes, obesity-prone C57BL/6J mice, age 13 wk, were treated with a high-fat (60% kcal) diet (Research Diets, New Brunswick, NJ) for 148 Ϯ 1 (means Ϯ SE) days and received a low (for mouse) dose of streptozotocin (STZ) (100 mg/kg) on day 56 following the onset of HF feeding (7) . Control C57BL/6J mice of the same age were fed normal rodent chow for 148 Ϯ 1 days and injected with saline rather than STZ in parallel to the diabetic group. When compared with other mouse strains, C57BL/6J mice gain substantially more weight and accumulate abundant adipose mass when fed diets high in fat (13, 31) . Although widely used in obesity studies, a specific gene defect accounting for their susceptibility to obesity has not been found.
Preparation of mitochondria. Total hindlimb muscle mitochondria were prepared by differential centrifugation and purification on a Percoll gradient as we have described in the past (36) . Mitochondrial integrity was assessed by cytochrome C release using a commercial kit (Cytochrome C Oxidase Assay Kit, Sigma-Aldrich, St. Louis, MO) indicating a mean of 96% intact mitochondria over three assays, well within an acceptable range compared with mitochondrial preparations from several sources (33) .
ADP recycling and generation of the 2-deoxyglucose energy clamp. We used a method that we recently developed (35) to carry out bioenergetic studies of isolated mitochondria under conditions of clamped ADP and membrane potential. Mitochondrial incubations were carried out in the presence of hexokinase (HK) and excess 2-deoxyglucose (2DOG) and varying amounts of added exogenous (ex vivo) ADP. ATP generated from ADP under these conditions drives the conversion of 2DOG to 2DOG phosphate (2DOGP) while regenerating ADP (Fig. 1A) . The reaction occurs rapidly and irreversibly, thereby effectively clamping ADP concentrations. Since ⌬⌿ is dependent on the rate of utilization of potential for ATP production, which is determined by the ADP concentration, keeping [ADP] constant also clamps ⌬⌿. Indeed, this was the case in the current study (Fig. 1, B and C) , as we have demonstrated in the past for mitochondria of rat (35) and mouse (1) skeletal muscle and mouse liver and heart (34) .
Respiration and membrane potential. Respiration and ⌬⌿ were simultaneously determined using an Oxygraph-2k high-resolution respirometer (Oroboros Instruments, Innsbruck, Austria) fitted with a potential-sensitive tetraphenylphosphonium (TPP ϩ ) electrode. Mitochondria (0.05 mg/ml) were incubated at 37°C in 2 ml of ionic respiratory buffer (105 mM KCl, 10 mM NaCl, 5 mM Na2HPO4, 2 mM MgCl2, 10 mM HEPES, pH 7.2, 1 mM EGTA, 0.2% defatted BSA) with 5 U/ml hexokinase (Worthington Biochemical), and 5 mM 2-DOG. Succinate (5 mM) was added as substrate to energize (provide electrons for oxidative metabolism) mitochondria at complex II (succinate dehydrogenase). ADP was added sequentially to the respiratory buffer to achieve the desired final concentrations with plateaus in respiration and potential achieved after each addition. A TPP ϩ standard curve was performed in each run by adding tetraphenylphosphonium chloride at concentrations of 0.25, 0.5, 0.75, and 1 M before the addition of mitochondria to the chamber.
Use of the 2DOG energy clamp to quantify ATP production in isolated mitochondria and simultaneous assessment of H2O2 production. Mitochondria (0.1 mg/ml) were added to individual wells of black polystyrene 96-well round bottom plates in a total volume of 60 l and incubated at 37°C in respiratory buffer plus 5 U/ml HK (Worthington Biochemical) and 5 mM 2DOG in the presence of selected concentrations of ADP. After incubation for 20 min with gentle rocking, the contents of the microplate wells were removed to tubes on ice containing 1 l of 120 M oligomycin to inhibit ATP synthase. Tubes were then centrifuged for 4 min at 14,000 g to pellet the mitochondria. Supernatants were transferred to new tubes and stored at Ϫ20°C for quantification of 2DOGP by nuclear magnetic resonance (NMR) spectroscopy. To prepare the NMR sample, 40 l of assay supernatant were added to a 5-mm (OD) standard NMR tube (Norell) along with 50 l of deuterium oxide (D2O) and 390 l of a buffer consisting of 120 mM KCl, 5 mM KH2PO4, and 2 mM MgCl2, pH 7.2. ATP production rates were calculated based on the percent conversion of 2DOG to 2DOGP, the initial 2DOG concentration, incubation volume, and incubation time. To simultaneously assess H2O2 production, mitochondrial incubations were carried out in the presence of 10-acetyl-3,7-dihydroxyphenoxazine (DHPA or Amplex Red) as described in Quantification of ATP by NMR spectroscopy.
Quantification of ATP by NMR spectroscopy. NMR spectra were collected at 37°C on a Bruker Avance II 500 MHz NMR spectrometer. Mitochondrial samples were studied by acquiring two-dimensional (2D) 1 H/ 13 C HSQC NMR spectra using [ 13 C]2DOG at C6 position ( [6- 13 C]2DOG) as we recently described (35) . The amount of 2DOG and 2DOGP present in the NMR samples were quantitatively measured using the peak intensities of the assigned resonances of these compounds. Representative spectra are shown in Fig. 2 . NMR spectra were processed with the NMRPipe package (12) and analyzed using NMRView software (19) . This ATP assay proved highly sensitive and specific and over 40 times more sensitive than NMR measurement of ATP per se (35) with a coefficient of variation of 2% based on four repetitions of the same sample and Ͻ5% variation on duplicate samples. This assay also has the advantage of requiring no fluorescent agent, so that measurements such as H 2O2 determinations using DHPA (or Amplex Red) can be carried out on the same samples.
Mitochondrial H 2O2 production. H2O2 production was assessed simultaneously with ATP production as we have described (36) using the fluorescent probe DHPA, a highly sensitive and stable substrate for horseradish peroxidase and a well-established probe for isolated . The values on the y-axis represent the recorded electrode potential as raw data. The actual mitochondrial inner membrane potential (⌬⌿) is calculated using the Nernst equation (14) and is inversely related to the electrode potential.
mitochondria (26) . Fluorescence was measured and quantification carried out as we previously described (24) . Addition of catalase, 500 U/ml, reduced fluorescence to below the detectable limit, indicating specificity for H 2O2. Addition of substrates to respiratory buffer without mitochondria did not affect fluorescence. DHPA does not interfere with ATP production or with NMR detection of 2DOGP (35) . To calculate H 2O2 production rates (in unit of pmol H2O2/min), we divided the linear change in fluorescence per unit time over 20-min incubations (signal intensity·min Ϫ1 ·well Ϫ1 ) by the known change in fluorescence per unit change in [H2O2] determined from a standard curve run with each assay (signal intensity·pmol Ϫ1 ·well Ϫ1 ). Statistics. Data were analyzed by two-way ANOVA using GraphPad Prism (GraphPad Software, La Jolla, CA). Significance was considered at P Ͻ 0.05. Table 1 , the diabetic group gained much more weight (14.9 g in diabetic vs. 1.1 g in control) and had far higher glucose at euthanasia (408 mg/ 100 ml in diabetic vs. 185 mg/100 ml in control). In our experience and in that of other investigators, nondiabetic mice often have glucose values near 200 mg/100 ml on cardiac blood obtained at euthanasia. So the mean value of blood glucose for the controls at 185 mg/100 ml is as expected.
RESULTS

Animal characteristics. As indicated in
Mitochondrial respiration. Mitochondria were energized with 5 mM succinate in the absence (Fig. 3A) or presence ( Fig.  3B ) of rotenone (5 M). As expected, in the presence of rotenone we observed a progressive increase in O 2 flux with incremental additions of clamped ADP for mitochondria isolated from both control and diabetic mice (Fig. 3B ). However, respiration by the diabetic mitochondria was decreased at all clamped concentrations of ADP above zero. For respiration on succinate without rotenone, we observed a different pattern. As expected based on our past studies of normal mouse muscle mitochondria (1), O 2 flux initially increased with increments in clamped [ADP] but only until [ADP] reached concentrations of 6 to 8 M (Fig. 3A) , beyond which respiration steadily declined to levels even below state 4. However, we observed a shift to the right in the curve of O 2 flux versus [ADP] for diabetic mitochondria with significantly increased respiration by the diabetic mitochondria at ADP concentrations of 7 and 8 M. Moreover, significant interaction was observed (diabetes status vs. ADP, P Ͻ 0.05) indicating that the effect of diabetes was dependent on [ADP] . When this type of experiment was done in the presence of oligomycin to block ATP synthase, ADP increments had no effect on respiration (data not shown). That is, respiration remained at state 4 indicating dependence on ATP production rather than ADP per se.
Inner mitochondrial membrane potential. Plateau values for mitochondrial membrane potential in succinate-energized mitochondria of both control and diabetic mice decreased continuously as [ADP] was increased (Fig. 4) . ⌬⌿ was significantly higher for mitochondria from the diabetic mice compared with control by two-way ANOVA (diabetes ϫ ADP, with no interaction) whether incubated with (P Ͻ 0.05) or without (P Ͻ 0.01) rotenone, although individual values were significantly different only at 7 M ADP and absence of rotenone ( (Fig. 5B) .
ATP production. Like respiration, ATP production rates by mitochondria energized by succinate alone increased at low Representative example of quantification of ATP production in control and diabetic mitochondria by two-dimensional 1 H/ 13 C HSQC NMR method. Shown is the overlay of two-dimensional 1 H/ 13 C HSQC spectra of the H6/C6 region of 2DOGP for samples that contain mitochondria from a control (black) mouse and a diabetic (red) mouse. Mitochondria (0.1 mg/ml) were incubated for 20 min in respiratory buffer containing 5.0 mM [6- 13 C]-2DOG, 5 U/ml hexokinase, and 4 M ADP and energized with 5.0 mM succinate alone. The peaks derived from ␣-2DOGP C6/H6 and ␤-2DOGP C6/H6 are labeled. The peak intensity of ␤-2DOGP C6/H6 was used for quantification of ATP production. One-dimensional slices through the ␤-2DOGP C6/H6 cross-peaks are also shown for clear illustration of the differences in peak intensity of the mitochondrial samples from control and diabetic mice.
[ADP] before decreasing at high [ADP] (Fig. 6A) . However, unlike the dynamics observed for O 2 flux versus [ADP] (Fig.  3A) , ATP production by diabetic mitochondria was much lower at all incremental values of [ADP] (Fig. 6A) . No significant differences were observed between the diabetic and control mitochondria incubated on succinate in the presence of rotenone (Fig. 6B) .
ROS production. Superoxide (measured indirectly as H 2 O 2 ) did not differ between the diabetic and control mitochondria when energized by succinate alone (Fig. 7A ). In the presence of rotenone, H 2 O 2 production was less in the diabetic mitochondria compared with control under state 4 conditions (0 ADP) but otherwise did not differ (Fig. 7B) . Since electron flux is the driving force for electron leak, we also examined reactive oxygen species (ROS) per unit respiration, which showed similar results (data not shown).
DISCUSSION
By using ADP recycling technology, we report new findings including decreased ATP production over a range of ADP concentrations by the diabetic mitochondria accompanied by a rightward shift in the dynamics of O 2 flux versus [ADP] . Importantly, the decrease in ATP production by the diabetic mitochondria was mainly due to decreased capacity to utilize ⌬⌿ for ATP synthesis and less affected by respiration or respiratory uncoupling. Moreover, we believe that the decrease in ATP production explains the rightward shift in O 2 flux versus [ADP]. The rationale for this interpretation is discussed below.
First, we point out that our current data confirm our past results (1) that demonstrated a biphasic respiratory response when ADP is added in incremental amounts to succinateenergized normal mouse hindlimb muscle, heart, and brain mitochondria. This biphasic response was not observed in mitochondria energized by succinate in the presence of rotenone or when complex I substrates were used (1). In those cases we observed only a continuous upward curve of O 2 flux versus [ADP] . Metabolite studies carried out in our previous work (1) suggested that the mechanism underlying the succinate-energized biphasic response of respiration to incremental ADP was multifactorial, including coordinate changes in directional electron flow (forward or reverse electron transport), altered NADH/NAD ϩ redox cycling, metabolite exit, and oxaloacetate inhibition of succinate dehydrogenase.
In this study, we assessed muscle mitochondrial function as affected by the high-fat, STZ diabetic mouse perturbation, a model of Type 2 diabetes. In contrast to performing experiments simply under state 4 and state 3 respiratory conditions, we assessed mitochondrial function over a range of clamped [ADP] concentrations; thereby enabling our observation of the rightward shift in the relationship of mitochondrial O 2 flux to [ADP] in the diabetic group (Fig. 3A) . Hence, the diabetic mice require more ADP to generate respiration. Based on the following considerations, we propose that this rightward shift represents compensation for dysfunction in mitochondrial capacity to make ATP.
Note that ATP production was less in our diabetic mitochondria respiring on succinate alone (Fig. 6A ) at all levels of [ADP] other than 0. This was true despite higher membrane potential (Fig. 4A) . Therefore, our findings imply that the mitochondria of the diabetic mice respiring on succinate alone make less ATP because of less capacity to utilize existing membrane potential to drive ATP synthesis as diagrammed in Fig. 8 . Clearly, changes in respiration and respiratory uncou- (clamped respiratory state) in freshly isolated hindlimb muscle mitochondria of control (n ϭ 9) and diabetic (n ϭ 13) mice. A: mitochondria energized by succinate (5 mM). B: mitochondria energized by succinate (5 mM) ϩ rotenone (5 M). Data represent means Ϯ SE. *P Ͻ 0.05 vs. control by 2-way ANOVA (diabetic status ϫ ADP). The overall factor effect of diabetes status was significant at P ϭ 0.010 in the absence of rotenone (A) and at P ϭ 0.019 in the presence of rotenone (B) with no significant interaction in either case.
pling can alter ATP synthesis. However, this does not alter our conclusion that utilization of membrane potential was impaired. This is because respiration and uncoupling can only alter ATP production indirectly by quantitatively altering ⌬⌿ (Fig. 8) ; which, according to the widely accepted chemiosmotic theory, is the only direct mediator of ATP synthase (5). Hence, decreased ATP production despite our observed increase or no decrease in the level of ambient ⌬⌿ means that utilization of this force by succinate-energized mitochondria was impaired. The above is not to say that perturbed respiration and respiratory uncoupling by the diabetic mitochondria had no impact to reduce ATP production, as these factors could do so by reducing ambient ⌬⌿. However, these effects appear much less in magnitude than capacity to utilize ⌬⌿. Respiration was only slightly lower in the diabetic mitochondria at the low ADP concentration of 4 M (Fig. 3A) and not significantly so. Moreover, uncoupling by the diabetic mitochondria was only greater at 7 and 8 M ADP (Fig. 5A ) and, therefore, cannot explain the decrease in ATP production we observed at the lower ADP concentrations of 4 and 6 M (Fig. 6A) .
From the above considerations, it appears highly likely that the rightward shift in the relationship between respiration and [ADP] (Fig. 3A) for the diabetic mitochondria was a consequence of impaired ability to use ⌬⌿ for ATP production. Decreased capacity to convert ADP to ATP means that mitochondrial membrane potential will not be reduced as much for a given increment in [ADP], consistent with the data in Fig. 4 . Since mitochondria are well known to increase respiration as ⌬⌿ is dissipated, the diabetic mitochondria will require a higher [ADP] to dissipate ⌬⌿ and achieve the same level of respiration as in the control organelles, thus providing an explanation for the rightward shift in O 2 flux versus [ADP] (Fig. 3A) .
We acknowledge that our data do not delineate the exact mechanism for the defect in utilization of membrane potential. Inability to harness potential could be due to a defect in membrane transport of nucleotides or phosphate for ATP synthesis or a defect anywhere in the function of the ATP synthase complex. Of note, our results are consistent with proteomic evidence for downregulation of phosphorylation of the catalytic component of ATP synthase in human Type 2 diabetes (18), with altered lysine acetylation of several subunits of ATP synthase in mice with STZ-induced diabetes (27) , and with decrease expression of the F1 ␣-subunit of the ATP synthase complex in heart of obese genetically diabetic db/db mice (2). Hence, this study provides previously unreported [ADP]-dependent functional data in a Type 2 diabetes model localizing defective ATP production to the use of ⌬⌿, in agreement with molecular events reported in other studies.
We also examined mitochondrial dynamics in the presence of rotenone, a specific inhibitor of complex I in isolated mitochondria (23) . Metabolic events in succinate-energized mitochondria, in the presence or absence of rotenone, are depicted in Fig. 9 . Succinate oxidation at complex II (succinate dehydrogenase or SDH) generates fumarate and malate. Malate can exit mitochondria by way of the dicarboxylate carrier or be converted to oxaloacetate, a known inhibitor of SDH (32, 37) . Conversion of malate to oxaloacetate requires NAD ϩ reduction to NADH at complex I. Rotenone inhibits complex I, preventing NAD ϩ /NADH cycling and oxaloacetate formation and, consequently, preventing inhibition of SDH. The result, for succinate-energized mitochondria in the presence of rotenone, is increased respiration along with increased malate exit. Interaction was significant at P ϭ 0.029 for mitochondria incubated in the absence of rotenone (A).
We carried out our rotenone studies first to show that the downturn in O 2 flux at high ADP (Fig. 3A) was not due to damaged mitochondria. This was not the case since the same mitochondrial preparations, with or without rotenone, were studied side by side in our dual chamber respirometer and no downturn was seen in the presence of rotenone (Fig. 3B) . Also, in our past studies of normal mouse muscle mitochondria respiring on succinate (1), we added rotenone after addition of sufficient ADP to inhibit respiration. We found that rotenone immediately (seconds) reversed the loss of respiration confirming that the downturn in respiration was not due to damaged mitochondria.
Second, we performed studies with rotenone to assess oxidation of succinate at complex II independent of tricarboxylic acid cycle events involving complex I as illustrated in Fig. 9 . Although rotenone is clearly not physiological, the compound has historically been used for this purpose (15) . In the current work, rotenone (compared with its absence) increased respiration, membrane potential, and ATP production (compare A and B in Figs. 3, 4, and 6 ). In diabetic mitochondria compared with controls, when incubated in the presence of rotenone, respiration and uncoupling were decreased (Figs. 3B and 5B) while ⌬⌿ and ATP production were unchanged (Figs. 4B and 6B) .
Therefore, the issue arises as to why the diabetic mitochondria generated substantially less ATP and less efficiently harnessed ⌬⌿ when energized by succinate alone but not when energized by succinate plus rotenone. Interestingly, this finding suggests that a functional complex I is somehow required for the diabetes-induced decrease in ATP production since a significant effect of diabetes was not observed in the presence of rotenone inhibition of this complex. However, this is a difficult issue since, as Fig. 9 indicates, rotenone markedly alters metabolic events. As we have previously reported (1), increments in ADP in normal mouse mitochondria respiring on succinate result in oxaloacetate accumulation and decreased fumarate and malate exit, implying changes in enzyme function, carrier proteins, or membrane properties. These ADP-induced changes were observed only in the absence but not in the presence of rotenone. So we can at least speculate that for succinate (alone)-energized mitochondria, diabetes affected function in a way that involved some or all of these factors. Future work will be needed to sort this out. Since the effects of ADP were immediate upon ADP addition, we expect that protein modifications and/or protein-protein interactions are involved and we are beginning proteomic as well as more metabolomic studies to address this issue. One could postulate that ROS production could impair proper utilization of ⌬⌿ for ATP production. However, unless a radical other than H 2 O 2 was involved, this does not explain our finding of impaired utilization of ⌬⌿ by the diabetic mitochondria, since there was no difference in H 2 O 2 generated by these mitochondria compared with controls in the absence of rotenone (Fig. 7A) .
We are not aware of other reports wherein mitochondrial function in Type 2 diabetes or obesity has been examined as we have herein using ADP recycling methodology and/or examining mitochondrial function over the complex II-energized biphasic course of ADP-dependent O 2 flux. In a past study of STZ-diabetic rats made severely insulin deficient (a type 1 model), we used the hexokinase/2-deoyyglucose clamp methodology to demonstrate continuously reduced respiration and ATP production over a range of [ADP] in gastrocnemius muscle. However, these mitochondria were fueled by combined glutamate, malate, and succinate rather than succinate alone, so neither the biphasic responsiveness nor the shift to the right in the relationship of O 2 flux to respiration were observed (35) . Reduced ADP-stimulated state 3, but not state 4, respiration has been reported in permeabilized human muscle studies of mitochondrial function energized by combined complex I and II substrates in Type 2 diabetes even when corrected for mitochondrial density (25 As described by Brand and Nicholls (5), mitochondrial membrane potential (⌬⌿) is determined by the balance between three factors or modules. These include: 1) oxygen consumption or respiration (minus a small percentage lost as ROS) which generates ⌬⌿ by proton pumping, 2) uncoupling (whether catalyzed by uncoupling proteins or because of nonspecific proton leak) which dissipates ⌬⌿, and 3) ATP production which utilizes ⌬⌿. Utilization of ⌬⌿ for ATP synthesis depends directly only on ⌬⌿ per se (and only indirectly on modules 1 and 2). Since ATP production by muscle mitochondria of the diabetic mice was decreased, whereas ⌬⌿ was increased, the reduction in ATP production was due to loss of capacity to utilize ⌬⌿ (as detailed in text).
versial as another report showed that mitochondrial respiration was normal when expressed per DNA content, suggesting that the impairment was not in function but in number of mitochondria (3). Our data in isolated mouse mitochondria imply a functional defect. As stated above, H 2 O 2 production rates did not significantly differ between mitochondria of control and diabetic mice after ADP addition whether rotenone was present or absent. However, H 2 O 2 production during state 4 respiration (no added ADP) was lower in the mitochondria of the diabetic group when rotenone was present. H 2 O 2 in succinate-energized mitochondria results from reverse-electron transport (RET) and largely represents superoxide generated at complex I and converted to H 2 O 2 by matrix superoxide dismutase (23, 24) . Rotenone, which blocks RET, markedly reduces H 2 O 2 production under these state 4 conditions (23, 24), as we observed herein (compare Fig. 7, A and B at 0 [ADP]). Hence, it is possible that defects in complex I in the diabetic mitochondria add to the rotenone-induced reduction in ROS under state 4 conditions (Fig. 7B) . We did not see a difference at 0 [ADP] in the absence of rotenone (Fig. 7A) , a circumstance wherein H 2 O 2 production and RET is known to be very high. Note that H 2 O 2 production actually drops lower at higher values of [ADP] in the absence of rotenone versus presence (compare Fig. 7, A and B) , an effect likely due to lower O 2 flux (compare Fig. 3, A and B) , i.e., less overall electron flow to molecular oxygen.
We do not think that the increase in O 2 flux in the diabetic versus control mitochondria at 7 and 8 M ADP (Fig. 3A) is due to ROS formation. This is because the percentage of total respiration directed at ROS production is no more than 4% under extreme conditions and generally would be much less, likely in the realm of Ͻ1% (4). Rather, we believe that the excess O 2 flux under this condition simply represents the electron flux needed to generate the increase in ⌬⌿ (Fig. 4A) .
Of further note is that the biphasic pattern of O 2 flux versus [ADP] in muscle mitochondria (Fig. 3A) was only detectable using ADP recycling methodology. We believe this is the reason why we could not find past description of this phenomenon before our recent report (1) . Moreover, we would also not have been able to detect the herein observed effect of HF/STZ diabetes on O 2 flux had we only examined respiration under state 4 and 3 conditions, as it was not manifest at either extreme.
We conclude that ATP production is impaired in muscle mitochondria energized at complex II of HF-fed STZ-treated diabetic and obese mice. This results from reduced capacity to utilize ⌬⌿ for ATP synthesis and explains the rightward shift in the dynamics relating complex II energized O 2 flux to [ADP]. Our results suggest a defect in the ATP synthase apparatus and/or in the mitochondrial transport of substances needed for ATP synthesis.
Perspectives and Significance
Skeletal muscle is critical to glucose utilization, exercise tolerance, and overall mobility. Impaired skeletal muscle function termed diabetic myopathy (17) is a known complication of Type 2 diabetes and is associated with mitochondrial dysfunction (8, 16) . Moreover, skeletal muscles are needed for respiration so impaired function could lead to respiratory fatigue (21, 28) . Our current results add to our basic understanding of these issues, providing new information about skeletal muscle mitochondrial ATP production initiated at mitochondrial complex II. Also of note is that our current findings were only evident by using ADP recycling methodology (as opposed to simply examining state 3 and state 4 respiration), suggesting that this approach to the study of mitochondrial physiology might be more widely applied in future studies. Oxidation of succinate at complex II generates fumarate, which is rapidly and very efficiently converted to malate. Malate can exit mitochondria through the dicarboxylate carrier or be converted to oxaloacetate (OAA). The latter requires NAD ϩ /NADH cycling at complex I. ROT (B) inhibits complex I, preventing NADH oxidation. This prevents OAA formation and, consequently, prevents inhibition of succinate dehydrogenase (SDH), resulting in increased respiration along with increased malate exit. Note that OAA cannot undergo further metabolism in the absence of a source of acetyl CoA. Thickness of arrows or lines and size of text depict magnitude of effects or concentrations. C I and C II depict complexes I and II. Green and red arrows depict forward electron transport (proportional to O2 flux) and reverse electron transport, respectively. The membrane charge differential (⌬⌿) (blue ϩ) is utilized for ATP production. The metabolite flow depicted above assumes the availability of moderate amounts of ADP (~4 M as shown in Figs. 3-7) . As described in the main text, variations in the concentrations of ADP will alter the metabolic events depicted above.
